PATHWAY CAPITAL MANAGEMENT, LP
Q3 2025 13F Holdings
- Locationirvine, CA
- Num holdings
7
- Value ($000)
$20,343
- Date Filed 11/04/2025
- Form type13F-HR
- CIK 0001037353
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
H HIMS & HERS HEALTH, INC. | COM CL A | 433000106 | $6.77M | 33 % | 119,279 | ||
A ARCELLX, INC. | COMMON STOCK | 03940C100 | $4.19M | 21 % | 51,051 | ||
G GOODRX HOLDINGS, INC. | COM CL A | 38246G108 | $4.17M | 21 % | 986,158 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | $3.24M | 16 % | 50,049 | ||
P PDD HOLDINGS INC. | SPONSORED ADS | 722304102 | $951.23K | 5 % | 7,197 | ||
N NU HOLDINGS LTD. | ORD SHS CL A | G6683N103 | $944.75K | 5 % | 59,010 | ||
N NEUEHEALTH INC | COM NEW | 10920V404 | $74.71K | 0 % | 11,201 |
Rows Per Page
10
- 10
- 50
- 100